Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Decker

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Clinical and Vaccine Immunology : CVI|September 19, 2014
Safety and immunogenicity of tetanus-diphtheria-acellular pertussis vaccine administered to children 10 or 11 years of ageGary S Marshall, Vitali Pool, David P Greenberg, et al.
The Pediatric Infectious Disease Journal|November 26, 2009
Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot studyEmmanuel B Walter, Janet A Englund, Mark Blatter, et al.
Expert Review of Vaccines|November 5, 2016
Fluzone® High-Dose Influenza VaccineCorwin A Robertson, Carlos A DiazGranados, Michael D Decker, et al.
Vaccine|September 14, 2020
Brand-specific rates of pertussis disease among Wisconsin children given 1-4 doses of pertussis Vaccine, 2010-2014James H Conway, Jeffrey P Davis, Jens C Eickhoff, et al.
Human Vaccines & Immunotherapeutics|July 9, 2016
Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccineRoger Baxter, John Hansen, Julius Timbol, et al.
Journal of the Pediatric Infectious Diseases Society|March 25, 2017
Immunogenicity of a Booster Dose of Quadrivalent Meningococcal Conjugate Vaccine in Previously Immunized HIV-Infected Children and YouthMeredith G Warshaw, George K Siberry, Paige Williams, et al.
The Pediatric Infectious Disease Journal|November 26, 2009
Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled studyJanet A Englund, Emmanuel Walter, Steven Black, et al.
Vaccine|December 12, 2012
Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adultsDavid P Greenberg, Corwin A Robertson, Michael J Noss, et al.
The Pediatric Infectious Disease Journal|January 22, 2014
Safety and immunogenicity of an inactivated quadrivalent influenza vaccine in children 6 months through 8 years of ageDavid P Greenberg, Corwin A Robertson, Victoria A Landolfi, et al.
Vaccine|July 5, 2016
Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlersJohn Hansen, Julius Timbol, Ned Lewis, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Clinical and Vaccine Immunology : CVI|September 19, 2014
Safety and immunogenicity of tetanus-diphtheria-acellular pertussis vaccine administered to children 10 or 11 years of ageGary S Marshall, Vitali Pool, David P Greenberg, et al.
The Pediatric Infectious Disease Journal|November 26, 2009
Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot studyEmmanuel B Walter, Janet A Englund, Mark Blatter, et al.
Expert Review of Vaccines|November 5, 2016
Fluzone® High-Dose Influenza VaccineCorwin A Robertson, Carlos A DiazGranados, Michael D Decker, et al.
Vaccine|September 14, 2020
Brand-specific rates of pertussis disease among Wisconsin children given 1-4 doses of pertussis Vaccine, 2010-2014James H Conway, Jeffrey P Davis, Jens C Eickhoff, et al.
Human Vaccines & Immunotherapeutics|July 9, 2016
Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccineRoger Baxter, John Hansen, Julius Timbol, et al.
Journal of the Pediatric Infectious Diseases Society|March 25, 2017
Immunogenicity of a Booster Dose of Quadrivalent Meningococcal Conjugate Vaccine in Previously Immunized HIV-Infected Children and YouthMeredith G Warshaw, George K Siberry, Paige Williams, et al.
The Pediatric Infectious Disease Journal|November 26, 2009
Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled studyJanet A Englund, Emmanuel Walter, Steven Black, et al.
Vaccine|December 12, 2012
Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adultsDavid P Greenberg, Corwin A Robertson, Michael J Noss, et al.
The Pediatric Infectious Disease Journal|January 22, 2014
Safety and immunogenicity of an inactivated quadrivalent influenza vaccine in children 6 months through 8 years of ageDavid P Greenberg, Corwin A Robertson, Victoria A Landolfi, et al.
Vaccine|July 5, 2016
Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlersJohn Hansen, Julius Timbol, Ned Lewis, et al.
Pageof 5